Vlahov D - Search Results

1

Vitamin A supplementation and human immunodeficiency virus load in injection drug users.

Semba RD, Lyles CM, Margolick JB, Caiaffa WT, Farzadegan H, Cohn S, Vlahov D. Semba RD, et al. Among authors: vlahov d. J Infect Dis. 1998 Mar;177(3):611-6. doi: 10.1086/514235. J Infect Dis. 1998. PMID: 9498439 Clinical Trial.

2

Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women.

Semba RD, Shah N, Klein RS, Mayer KH, Schuman P, Vlahov D; Human Immunodeficiency Virus Epidemiology Research Study Group. Semba RD, et al. Among authors: vlahov d. Clin Infect Dis. 2002 Jan 15;34(2):260-6. doi: 10.1086/338151. Epub 2001 Dec 4. Clin Infect Dis. 2002. PMID: 11740716

3

High prevalence of iron deficiency and anemia among female injection drug users with and without HIV infection.

Semba RD, Shah N, Strathdee SA, Vlahov D. Semba RD, et al. Among authors: vlahov d. J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):142-4. doi: 10.1097/00042560-200202010-00005. J Acquir Immune Defic Syndr. 2002. PMID: 11832682

4

Risk factors and cumulative incidence of anaemia among HIV-infected injection drug users.

Semba RD, Shah N, Vlahov D. Semba RD, et al. Among authors: vlahov d. Int J STD AIDS. 2002 Feb;13(2):119-23. doi: 10.1258/0956462021924758. Int J STD AIDS. 2002. PMID: 11839167

5

Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.

Margolick JB, Muñoz A, Vlahov D, Solomon L, Astemborski J, Cohn S, Nelson KE. Margolick JB, et al. Among authors: vlahov d. JAMA. 1992 Mar 25;267(12):1631-6. JAMA. 1992. PMID: 1347321

6

Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.

Chaisson RE, Taylor E, Margolick JB, Muñoz A, Solomon L, Cohn S, Nelson KE, Vlahov D. Chaisson RE, et al. Among authors: vlahov d. J Acquir Immune Defic Syndr (1988). 1992;5(5):456-60. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1348535

7

Prognostic indicators for development of AIDS among intravenous drug users.

Muñoz A, Vlahov D, Solomon L, Margolick JB, Bareta JC, Cohn S, Astemborski J, Nelson KE. Muñoz A, et al. Among authors: vlahov d. J Acquir Immune Defic Syndr (1988). 1992;5(7):694-700. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1613668

8

Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV).

Nelson KE, Vlahov D, Cohn S, Odunmbaku M, Lindsay A, Antohony JC, Hook EW 3rd. Nelson KE, et al. Among authors: vlahov d. J Infect Dis. 1991 Sep;164(3):457-63. doi: 10.1093/infdis/164.3.457. J Infect Dis. 1991. PMID: 1869836

9

Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.

Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Vlahov D. Caiaffa WT, et al. Among authors: vlahov d. Arch Intern Med. 1995 Oct 23;155(19):2111-7. Arch Intern Med. 1995. PMID: 7575072

10

Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users.

Markham RB, Yu X, Farzadegan H, Ray SC, Vlahov D. Markham RB, et al. Among authors: vlahov d. J Infect Dis. 1995 Apr;171(4):797-804. doi: 10.1093/infdis/171.4.797. J Infect Dis. 1995. PMID: 7706805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

699 results

Search Page

Filters